• talaris therapeutics stock hits 52-week low at $11.85 Investing.com Australia Thu, 10 Apr 2025 05:55:12 GMT
• How the (TRML) price action is used to our Advantage news.stocktradersdaily.com Wed, 26 Mar 2025 12:22:00 GMT
• talaris therapeutics stock hits 52-week low at $12.06 by investing.com Investing.com South Africa Mon, 24 Feb 2025 08:00:00 GMT
• top 40+ startups in hematopoietic stem cell therapy in jan, 2025 Tracxn Thu, 23 Jan 2025 08:00:00 GMT
• top 40+ startups in hematopoietic stem cell therapy in nov, 2024 Tracxn Mon, 25 Nov 2024 08:00:00 GMT
• top 40+ startups in hematopoietic stem cell therapy in nov, 2024 Tracxn Tue, 05 Nov 2024 08:00:00 GMT
• trml - tourmaline bio, inc. latest stock news & market updates StockTitan Tue, 15 Oct 2024 00:15:30 GMT
• top 40+ startups in hematopoietic stem cell therapy in oct, 2024 Tracxn Wed, 09 Oct 2024 07:00:00 GMT
• hematopoietic stem cell transplantation global market report 2024 size and forecast WhaTech Fri, 20 Sep 2024 20:12:56 GMT
• top 40+ startups in hematopoietic stem cell therapy in aug, 2024 Tracxn Wed, 28 Aug 2024 07:00:00 GMT
• ohsu accused of negligence in use of experimental treatment Willamette Week Thu, 22 Aug 2024 07:00:00 GMT
• talaris therapeutics closes $115 million series b financing Barchart Mon, 08 Jul 2024 19:22:47 GMT
• skye bioscience appoints dr. karen smith to board of directors GlobeNewswire Wed, 03 Jul 2024 07:00:00 GMT
• why talaris therapeutics shares are trading higher by around 8%; here are 20 stocks moving premarket Quantisnow Sun, 30 Jun 2024 07:19:56 GMT
• tourmaline bio promotes ryan robinson to cfo post (nasdaq:trml) Seeking Alpha Thu, 27 Jun 2024 12:23:37 GMT
• talaris therapeutics (tals) price target increased by 562.50% to 135.15 MSN Mon, 24 Jun 2024 04:16:01 GMT
• we're hopeful that talaris therapeutics (nasdaq:tals) will use its cash wisely Yahoo New Zealand News Mon, 06 May 2024 05:15:59 GMT
• cullinan therapeutics appoints mary kay fenton as chief financial officer citybiz Mon, 29 Apr 2024 07:00:00 GMT
• cullinan therapeutics names mary kay fenton chief financial officer MarketWatch Mon, 29 Apr 2024 07:00:00 GMT
• talaris therapeutics to participate at the 5th annual evercore isi healthconx conference Quantisnow Thu, 25 Apr 2024 05:16:14 GMT
• kidney transplant rejection market to witness upsurge in growth during the forecast period (2023-2032), examine ... Barchart Fri, 12 Apr 2024 13:42:00 GMT
• top premarket decliners -march 21, 2024 at 09:58 am edt Marketscreener.com Thu, 21 Mar 2024 13:58:11 GMT
• talaris plants bulk out nybce cdmo biz - bioprocess insider BioProcess Insider Thu, 29 Feb 2024 16:22:36 GMT
• diffuse cutaneous systemic sclerosis (dcssc) market to witness growth by 2032, estimates delveinsight | kadmon ... A spasso con Smith Wed, 07 Feb 2024 08:00:00 GMT
• tourmaline bio director discloses purchase of stake worth $3.25m (nasdaq:trml) Seeking Alpha Thu, 01 Feb 2024 08:00:00 GMT
• hsct market to record growth of usd 2.38 billion between 2022 and 2027, north america to occupy 40% market share - technavio The Malaysian Reserve Wed, 31 Jan 2024 08:00:00 GMT
• new hope for organ transplantation: life without anti-rejection drugs upworthyscience.com Sat, 27 Jan 2024 08:00:00 GMT
• tourmaline bio completes merger and rebrands operations - tipranks.com TipRanks Thu, 25 Jan 2024 08:00:00 GMT
• foley represents tcgx as investor in tourmaline bio, concurrent with merger with talaris therapeutics Foley & Lardner LLP Wed, 24 Jan 2024 08:00:00 GMT
• foley represents customer fulfillment robotics company instock in latest funding round Foley & Lardner LLP Thu, 11 Jan 2024 08:00:00 GMT
• fierce biotech layoff tracker 2023: reneo reduces workforce by 70%; oxurion cuts staff down to 10 Fierce Biotech Fri, 29 Dec 2023 08:00:00 GMT
• programs dropped, jobs lost: pipeline dynamics drive biopharma restructurings in 2023 BioWorld Online Mon, 18 Dec 2023 08:00:00 GMT
• tourmaline bio joins nasdaq biotechnology index -december 15, 2023 at 04:17 pm est Marketscreener.com Fri, 15 Dec 2023 21:17:10 GMT
• jefferies starts coverage on tourmaline bio with buy rating, $41 price target Marketscreener.com Fri, 15 Dec 2023 14:14:06 GMT
• jefferies starts coverage on tourmaline bio with buy rating, $41 price target Marketscreener.com Thu, 14 Dec 2023 21:00:00 GMT
• tourmaline bio appoints clay siegall as its chair (nasdaq:trml) Seeking Alpha Thu, 14 Dec 2023 12:45:41 GMT
• tourmaline bio appoints dr. clay siegall as chairman of the board Marketscreener.com Thu, 14 Dec 2023 12:31:02 GMT
• biotech company hopes to make louisville a hub for cell therapy WDRB Wed, 13 Dec 2023 02:56:56 GMT
• a new approach to kidney transplants would reprogram the immune system Leaps.org Tue, 12 Dec 2023 19:32:31 GMT
• Biotech company hopes to make Louisville a hub for cell therapy WDRB Tue, 12 Dec 2023 08:00:00 GMT
• prelude capital management llc invests $48000 in talaris therapeutics, inc. (nasdaq:tals) Defense World Sun, 10 Dec 2023 02:07:49 GMT
• biopharma layoff tracker 2023: travere, pfizer, orna and more cut ... BioSpace Tue, 05 Dec 2023 18:33:41 GMT
• biopharma layoff tracker 2023: pfizer, orna, kite and more cut staff BioSpace Fri, 01 Dec 2023 08:00:00 GMT
• Medeor cell therapy helps kidney transplant patients taper off immunosuppressant meds Fierce Biotech Thu, 02 Nov 2023 07:00:00 GMT
• cell therapy allows kidney recipients to cut immunosuppressants Fierce Biotech Thu, 02 Nov 2023 07:00:00 GMT
• tourmaline bio says ceo kulkarni buys 9.65k shares in co (nasdaq:trml) Seeking Alpha Fri, 27 Oct 2023 07:00:00 GMT
• american arab chamber of commerce building economic bridges gala MyLO | Sun, 22 Oct 2023 01:04:06 GMT
• talaris thera (nasdaq: tals) stock to jump 1,000% then fall $15 - weird and complex Dhaka Tribune Fri, 20 Oct 2023 07:00:00 GMT
• tourmaline shifts focus to developing anti-il6 antibody following merger Clinical Trials Arena Fri, 20 Oct 2023 07:00:00 GMT
• tourmaline bio announces closing of merger with talaris therapeutics and concurrent private placement of $75 million Stock Titan Thu, 19 Oct 2023 07:00:00 GMT
• why talaris therapeutics shares are trading higher by around 8%; here are 20 stocks moving premarket by benzinga Investing.com UK Wed, 18 Oct 2023 07:00:00 GMT
• talaris therapeutics announces stockholder approval of merger with tourmaline bio GlobeNewswire Tue, 17 Oct 2023 07:00:00 GMT
• talaris shareholders approve merger, 1-for-10 reverse stock split (tals) Seeking Alpha Tue, 17 Oct 2023 07:00:00 GMT
• talaris therapeutics (tals) announces stockholder approval of ... StreetInsider.com Tue, 17 Oct 2023 07:00:00 GMT
• will talaris therapeutics inc (tals) beat the rest of the stocks in the healthcare sector? InvestorsObserver Mon, 16 Oct 2023 07:00:00 GMT
• rsv vaccine maintains efficacy across two seasons in seniors Medpage Today Sun, 15 Oct 2023 07:00:00 GMT
• is talaris therapeutics inc (tals) a leader in the biotechnology industry? InvestorsObserver Thu, 12 Oct 2023 07:00:00 GMT
• is talaris therapeutics inc (tals) stock about to get hot monday? InvestorsObserver Mon, 09 Oct 2023 07:00:00 GMT
• talaris therapeutics declares special dividend in connection with proposed merger with tourmaline bio GlobeNewswire Fri, 06 Oct 2023 07:00:00 GMT
• talaris plants bulk out nybce cdmo biz - bioprocess insider BioProcess Insider Fri, 06 Oct 2023 07:00:00 GMT
• stocks to watch: shift technologies, talaris therapeutics, lockheed martin MarketWatch Fri, 06 Oct 2023 07:00:00 GMT
• in brief this week: avenge bio, mainz biomed, nkgen biotech ... Precision Medicine Online Fri, 06 Oct 2023 07:00:00 GMT
• former talaris therapeutics facility in louisville sold to new york biotech company - louisville business first The Business Journals Wed, 04 Oct 2023 07:00:00 GMT
• shareholder alert: morris kandinov investigating ael, cpri ... GlobeNewswire Mon, 02 Oct 2023 07:00:00 GMT
• histogen consigned to history after search for strategic solutions ... FierceBiotech Tue, 19 Sep 2023 07:00:00 GMT
• key cell differences due to antibody type found in dcssc patients... Scleroderma News Thu, 07 Sep 2023 07:00:00 GMT
• private firms' alternate route to ipo: the reverse merger Crain's New York Business Wed, 30 Aug 2023 07:00:00 GMT
• no product, no sales, no prospects? consider a reverse merger Mergers & Acquisitions Tue, 29 Aug 2023 07:00:00 GMT
• tourmaline bio announces fda clearance of investigational new ... Ophthalmology Times Mon, 28 Aug 2023 07:00:00 GMT
• fierce biotech analysis: 2023 biopharma layoffs now match 2022's ... FierceBiotech Mon, 21 Aug 2023 07:00:00 GMT
• aurinia appoints two new board directors with deep experience in ... Business Wire Mon, 21 Aug 2023 07:00:00 GMT
• breakout stocks today | stocks trading above 50-day moving ... MarketBeat Fri, 18 Aug 2023 07:00:00 GMT
• immunofree inc. has acquired talaris therapeutics, inc.'s tolerance ... Yahoo Finance Mon, 14 Aug 2023 07:00:00 GMT
• alert: the m&a class action firm continues investigating the merger – scu, tals, nltx, ccf ForexTV.com Mon, 07 Aug 2023 07:00:00 GMT
• immune tolerance via fcr001 cell therapy compared with maintenance immunosuppression for kidney transplantation: real-world eviden... Wiley Online Library Thu, 03 Aug 2023 07:00:00 GMT
• 12 acciones de salud en movimiento durante la preapertura del 26 ... Benzinga España Wed, 26 Jul 2023 07:00:00 GMT
• talaris therapeutics: cashing out ahead of tourmaline merger (nasdaq:tals) Seeking Alpha Tue, 18 Jul 2023 07:00:00 GMT
• shift technologies to continue strategic review -july 11, 2023 at ... Marketscreener.com Tue, 11 Jul 2023 07:00:00 GMT
• viridian looks to beat horizon's tepezza in thyroid eye disease FierceBiotech Mon, 10 Jul 2023 07:00:00 GMT
• histogen could be history as biotech halts all programs to conserve ... FierceBiotech Thu, 06 Jul 2023 07:00:00 GMT
• biotech layoffs 2023: in q2, more than 700 boston-area life science ... The Business Journals Mon, 03 Jul 2023 07:00:00 GMT
• shareholder notice: brodsky & smith announces an investigation of talaris therapeutics, inc. (nasdaq – tals) GlobeNewswire Mon, 26 Jun 2023 07:00:00 GMT
• talaris therapeutics investor alert by the former attorney general of louisiana: kahn swick & foti, llc investigates merger of tal... Financial Content Sat, 24 Jun 2023 07:00:00 GMT
• Talaris Therapeutics to merge with Tourmaline Bio Pharmaceutical Technology Fri, 23 Jun 2023 07:00:00 GMT
• june 22 quick takes: spyre launches onto nasdaq via aeglea merger BioCentury Fri, 23 Jun 2023 07:00:00 GMT
• premarket mover: talaris therapeutics inc (tals) down 3.33% InvestorsObserver Fri, 23 Jun 2023 07:00:00 GMT
• ky inno - talaris therapeutics announces merger after layoffs The Business Journals Fri, 23 Jun 2023 07:00:00 GMT
• svb securities serves as exclusive financial advisor for talaris therapeutics’ (nasdaq: tals) proposed merger with ... SVB Leerink Fri, 23 Jun 2023 07:00:00 GMT
• talaris soars on all stock deal with tourmaline bio - tipranks.com TipRanks Thu, 22 Jun 2023 14:12:25 GMT
• Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement GlobeNewswire Thu, 22 Jun 2023 07:00:00 GMT
• Tourmaline Bio, Talaris Therapeutics Announce Reverse Merger in Stock Deal BioSpace Thu, 22 Jun 2023 07:00:00 GMT
• Talaris, Tourmaline to combine in biotech’s latest reverse merger BioPharma Dive Thu, 22 Jun 2023 07:00:00 GMT
• Tourmaline heads to Nasdaq, inking Talaris reverse merger to fund midphase trials of Pfizer castoff Fierce Biotech Thu, 22 Jun 2023 07:00:00 GMT
• Tourmaline Bio reverse merges into Talaris and raises funds to target thyroid eye disease and pharma rivals Endpoints News Thu, 22 Jun 2023 07:00:00 GMT
• merger with talaris to advance tourmaline’s hidden gem for ted BioWorld Online Thu, 22 Jun 2023 07:00:00 GMT
• talaris, tourmaline to combine in biotech's latest reverse merger BioPharma Dive Thu, 22 Jun 2023 07:00:00 GMT
• talaris reverse merger tees up midphase trials of ex-pfizer drug Fierce Biotech Thu, 22 Jun 2023 07:00:00 GMT
• merger with talaris to advance tourmaline's hidden gem for ted BioWorld Online Thu, 22 Jun 2023 07:00:00 GMT
• ny biotech to go public by merging with boston firm that laid off 95% of staff - boston business journal The Business Journals Thu, 22 Jun 2023 07:00:00 GMT
• tourmaline bio agrees to merge with talaris therapeutics // cooley ... Cooley LLC Thu, 22 Jun 2023 07:00:00 GMT
• crude oil down over 4%; innovative eyewear shares plummet - (agle), allovir (nasdaq:alvr) Benzinga Thu, 22 Jun 2023 07:00:00 GMT
• have talaris therapeutics insiders been selling stock? \ Simply Wall St Sat, 17 Jun 2023 07:00:00 GMT
• biopharma layoff tracker 2023: rejuvenate, greenlight biosciences ... PharmaLive Wed, 14 Jun 2023 07:00:00 GMT
• a new approach to kidney transplants would reprogram the immune system Leaps.org Wed, 07 Jun 2023 07:00:00 GMT
• facing bankruptcy, rna-focused oncorus lays off 'substantially' all its staff Fierce Biotech Fri, 02 Jun 2023 07:00:00 GMT
Talaris Therapeutics Inc(NASDAQ:TALS) 
Talaris Therapeutics, Inc. is a late-clinical stage biopharmaceutical company developing investigational, one-time, allogeneic cell therapies with the potential to transform the standard of care in solid organ transplantation, certain severe autoimmune diseases, and certain severe non-malignant bloo...
Website: https://talaristx.com/
Founded: 1998
CEO: Scott Requadt
Sector: Professional, Scientific, and Technical Services
Industry: Research and Development in Biotechnology
Share this website to your friends